INVX Rule 144: Insider sale of 331,025 shares

Issuer: INVX (NYSE) notice of proposed sale under Rule 144 involving common stock tied to a prior stock award.

Rhea-AI Filing Summary

Issuer: INVX (NYSE) notice of proposed sale under Rule 144 involving common stock tied to a prior stock award.

Broker is UBS Financial Services, Inc.. The filing shows Adam Anderson reported sales of 331,025 common shares on 01/14/2026, and the securities originate from a stock award dated 12/31/2016.

Insights

Securities Compliance Attorney

Rule 144 notice records a proposed/reported sale by an insider from a 2016 stock award.

The filing lists Adam Anderson and a reported sale quantity of 331,025 common shares dated 01/14/2026. The broker on the form is UBS Financial Services, Inc..

Timing and exact cash proceeds are not provided in the excerpt; subsequent SEC or broker statements would disclose settlement and proceeds details if required.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does INVX's Form 144 show about insider sales?

The Form 144 shows Adam Anderson reported sale activity of 331,025 common shares with a reported date of 01/14/2026. It ties the shares to a stock award dated 12/31/2016 and lists UBS Financial Services as broker.

Who is the broker listed on the INVX Form 144?

The broker identified is UBS Financial Services, Inc. at 11 Madison Ave, New York. The form lists the broker in the securities information section and in connection with the proposed sale activity.

Are the shares from an award or open‑market holdings in INVX's filing?

The filing identifies the securities as from a Stock Award with a grant date of 12/31/2016. The entry labels the transaction source as Issuer, indicating the shares originate from an award.

Does the Form 144 state how much cash INVX or the insider received?

The excerpt does not state cash proceeds or price information. The form lists the number of shares reported (331,025) and dates but does not provide sale price or aggregate proceeds.

What date is associated with the filing and exchange for INVX?

The filing excerpt includes a market/exchange indicator NYSE and a date field 02/23/2026 in the securities information section, displayed alongside other listed figures.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 04:41 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002025643
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Innovex International, Inc.
SEC File Number	001-13439
Address of Issuer	19120 KENSWICK DRIVE HUMBLE TEXAS 77338
Phone	3463980000
Name of Person for Whose Account the Securities are To Be Sold	Anderson Adam
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	13241	357507.00	68927791	02/23/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/31/2016	Stock Award	Issuer			13241	12/31/2016	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Adam Anderson 19120 KENSWICK DRIVE Humble TX 77338	Common	01/14/2026	13241	331025.00

144: Remarks and Signature

Remarks
Date of Notice	02/23/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/14/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Adam Anderson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)